These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19003545)

  • 1. Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer.
    Cicin I; Karagol H; Usta U; Sezer A; Uzunoglu S; Alas-Cosar R; Yetisyigit T; Uygun K
    Med Oncol; 2009; 26(3):335-43. PubMed ID: 19003545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
    Wang X; Cai L; Ye F; Li M; Ma L; Geng C; Song Z; Liu Y
    Medicine (Baltimore); 2019 Sep; 98(36):e16937. PubMed ID: 31490377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the relevance between molecular subtypes and efficacy of neoadjuvant chemotherapy in breast cancer as well as its prognostic factors.
    Li F; Ma L; Geng C; Liu C; Deng H; Yue M; Ding Y; Wang X; Liu Y
    Pathol Res Pract; 2018 Aug; 214(8):1166-1172. PubMed ID: 29945816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?
    Basaran G; Devrim C; Caglar HB; Gulluoglu B; Kaya H; Seber S; Korkmaz T; Telli F; Kocak M; Dane F; Yumuk FP; Turhal SN
    Med Oncol; 2011 Sep; 28(3):726-32. PubMed ID: 20390469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?
    Park YH; Kim ST; Cho EY; Choi YL; Ok ON; Baek HJ; Lee JE; Nam SJ; Yang JH; Park W; Choi DH; Huh SJ; Ahn JS; Im YH
    Breast Cancer Res Treat; 2010 Feb; 119(3):653-61. PubMed ID: 19957028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and prognosis of different subtypes of breast cancer].
    Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-year follow-up of triple-negative breast cancer patients in Taiwan.
    Lin C; Chien SY; Kuo SJ; Chen LS; Chen ST; Lai HW; Chang TW; Chen DR
    Jpn J Clin Oncol; 2012 Mar; 42(3):161-7. PubMed ID: 22287721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival.
    Oven Ustaalioglu BB; Balvan O; Bilici A; Develi A; Aliustaoglu M; Vardar FA; Erkol B
    Clin Transl Oncol; 2015 Nov; 17(11):895-902. PubMed ID: 26081286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of hormone receptor status conversion following neoadjuvant chemotherapy in a series of operable breast cancer patients.
    Tan QX; Qin QH; Yang WP; Lian B; Wei CY
    Int J Clin Exp Pathol; 2014; 7(7):4086-94. PubMed ID: 25120787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
    Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
    BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics and prognostic factors in patients with operable HER-2 overexpressing breast cancer.
    Liu AN; Sun P; Liu JN; Ma JB; Qu HJ; Zhu H; Yu CY; Zhang LM
    Asian Pac J Cancer Prev; 2012; 13(4):1197-201. PubMed ID: 22799305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype.
    Yi SY; Ahn JS; Uhm JE; Lim DH; Ji SH; Jun HJ; Kim KH; Chang MH; Park MJ; Cho EY; Choi YL; Park YH; Im YH
    BMC Cancer; 2010 Oct; 10():527. PubMed ID: 20920367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of metastasis and survival in breast cancer patients: a preliminary study in an Iranian population.
    Ziaei JE; Pourzand A; Bayat A; Vaez J
    Asian Pac J Cancer Prev; 2012; 13(3):937-40. PubMed ID: 22631675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effect of neoadjuvant chemotherapy on biomarkers expression; assessment by digital image analysis and relationship to residual cancer burden in patients with invasive breast cancer.
    Cockburn A; Yan J; Rahardja D; Euhus D; Peng Y; Fang Y; Rumnong Sarode V
    Hum Pathol; 2014 Feb; 45(2):249-58. PubMed ID: 24289969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.